Evidence map›Paper›PMID 31576909›Full record

ArticleEinstein (Sao Paulo, Brazil)2020

Sericin as treatment of obesity: morphophysiological effects in obese mice fed with high-fat diet.

Regina Inês Kunz, Angélica Novi Capelassi, Ana Cláudia Paiva Alegre-Maller, Maria Lúcia Bonfleur, Lucinéia de Fátima Chasko Ribeiro, Rose Meire Costa, Maria Raquel Marçal Natali

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Recycled Sericin Biopolymer in Biotechnology and Bioelectronics.Bioengineering (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Heliyon · 2022
    Review
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Regina Inês KunzUniversidade Federal da Fronteira Sul, Passo Fundo, RS, Brazil.ORCID http://orcid.org/0000-0003-1510-7022
Angélica Novi CapelassiUniversidade Estadual do Oeste do Paraná, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0001-8477-8247
Ana Cláudia Paiva Alegre-MallerUniversidade Estadual do Oeste do Paraná, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0003-3777-7406
Maria Lúcia BonfleurUniversidade Estadual do Oeste do Paraná, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0001-5526-7421
Lucinéia de Fátima Chasko RibeiroUniversidade Estadual do Oeste do Paraná, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0001-5174-7399
Rose Meire CostaUniversidade Estadual do Oeste do Paraná, Cascavel, PR, Brazil.ORCID http://orcid.org/0000-0002-5344-5076
Maria Raquel Marçal NataliUniversidade Estadual do Maringá, Maringá, PR, Brazil.ORCID http://orcid.org/0000-0002-7486-2581
Universidade Estadual do Oeste do Paraná · BRUniversidade Estadual de Maringá · BRUniversidade Federal da Fronteira Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effects of sericin extracted from silkworm Bombyx mori cocoon on morphophysiological parameters in mice with obesity induced by high-fat diet.

methodsMale C57Bl6 mice aged 9 weeks were allocated to one of two groups - Control and Obese, and fed a standard or high-fat diet for 10 weeks, respectively. Mice were then further subdivided into four groups with seven mice each, as follows: Control, Control-Sericin, Obese, and Obese-Sericin. The standard or high fat diet was given for 4 more weeks; sericin (1,000mg/kg body weight) was given orally to mice in the Control-Sericin and Obese-Sericin Groups during this period. Weight gain, food intake, fecal weight, fecal lipid content, gut motility and glucose tolerance were monitored. At the end of experimental period, plasma was collected for biochemical analysis. Samples of white adipose tissue, liver and jejunum were collected and processed for light microscopy analysis; liver fragments were used for lipid content determination.

resultsObese mice experienced significantly greater weight gain and fat accumulation and had higher total cholesterol and glucose levels compared to controls. Retroperitoneal and periepididymal adipocyte hypertrophy, development of hepatic steatosis, increased cholesterol and triglyceride levels and morphometric changes in the jejunal wall were observed.

conclusionPhysiological changes induced by obesity were not fully reverted by sericin; however, sericin treatment restored jejunal morphometry and increased lipid excretion in feces in obese mice, suggesting potential anti-obesity effects.

Indexed as

Diet, High-FatAdipose TissueAnimalsAnti-Obesity AgentsBody WeightCholesterolEatingFatty LiverGastrointestinal TransitGlucose Tolerance TestLiverMaleMice, Inbred C57BLMice, ObeseObesityReproducibility of ResultsAnti-Obesity AgentsCholesterolSericinsTriglycerides

Identifiers

PMID31576909
PMCPMC6905161
OpenAlexW2977070045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.